Monsanto (MON) Merger Spread Widens as Doubts Grow
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
The merger arb spread on yesterday's massive $66 billion takeover of Monsanto (NYSE: MON) by Bayer is heading in the wrong direction, according to StreetInsider's Merger Arbitrage tracker. Yesterday, Monsanto agreed to be taken over for $128 per share in cash but today the stock is trading down to $104.56. With the drop, the spread has widened by 2.5% to 22.4%. As a comparison, the spread on the deals that are expected to close would only be a few percentage points. Meanwhile, the spread on Anthem (NYSE: ANTM)/Cigna (NYSE: CI), a deal that is expected to fall apart, is 30.8%.
If the deal goes through investors can make a return of 22.4% for doing no work. However "if" is the key word. The large spread is a major red-flag.
With the deal not expected to close until the end of 2017 there is a lot of time for things to go wrong. Politicians are already clamoring against the deal and antitrust attorneys are readying their pencils.
Some arbs only see a 50-50 chance of the deal closing.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pandora (P) Advisers Said to Begin Reaching Out to Possible Suitors Following Approach from Sirius (SIRI) - Bloomberg
- SoTHERLY Hotels (SOHO) Approves $10M Stock Buyback Plan
- Ladder Capital (LADR) to Explore Sale - Reuters
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors, Trader Talk
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!